Skip to main content
  • 1238 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 89.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur zu Kapitel 5

  • Aisner J (1995) Current approach to malignant mesothelioma of the pleura. Chest 107:332S–344S

    PubMed  CAS  Google Scholar 

  • Antman KH, Corson JM, Li FP et al. (1983) Malignant mesothelioma following radiation exposure. J Clin Oncol 1:695–700

    PubMed  CAS  Google Scholar 

  • Antman KH (1981) Clinical presentation and natural history of benign and malignant mesothelioma. Semin Oncol 8:313–320

    PubMed  CAS  Google Scholar 

  • Antman KH, Shemin R, Ryan L et al. (1988) Malignant mesothelioma: prognostic variables in a registry of 180 patients. The Dana-Farber Cancer Institute and Brigham and Women’s Hospital experiences over two decades 1965–1985. J Clin Oncol 6:147–153

    PubMed  CAS  Google Scholar 

  • Antman KH, Pass HI, Schiff PB (2001) Management of mesothelioma. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer — principles and practice of oncology, 6th edn. Lippincott, Philadelphia, pp 1943–1969

    Google Scholar 

  • Beauchamp KD, Kundra NK, Aranson R et al. (1992) The role of closed pleural needle biopsy in the diagnosis of malignant mesothelioma of the pleura. Chest 102:1110–1112

    PubMed  CAS  Google Scholar 

  • Bischoff HG, Manegold C, Knopp M et al. (1998) Gemcitabine may reduce tumor load and tumor associated symptoms in malignant pleural mesothelioma. Proc ASCO 17:464a

    Google Scholar 

  • Bittmann I, Wöckel W (2003) Pleuratumoren. In: Schalhorn A, Huber R (Hrsg) Manual Tumoren der Lunge und des Mediastinums. Tumorzentrum München. Zuckschwerdt, München

    Google Scholar 

  • Bittner R, Schnoy N, Schönfeld N et al. (1995) Hochauflösende Magnetresonanztomographie (HR-MRT) von Pleura und Thoraxwand: Normalbefund und pathologische Veränderungen. Fortschr Röntgenstr 162:296–303

    CAS  Google Scholar 

  • Boutin C, Rey F, Viallat JR (1995) Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma: a randomized trial of local radiotherapy. Chest 108:754–758

    PubMed  CAS  Google Scholar 

  • Boutin C, Rey F (1993) Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis. Cancer 72:389–393

    Article  PubMed  CAS  Google Scholar 

  • Bültzingslöwen F von (1996) Die Therapie des malignen Pleuramesothelioms. Atemw Lungenkr 22:644–653

    Google Scholar 

  • Butchart EG, Ashcroft T, Barnsley WC et al. (1976) Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 31:15–24

    PubMed  CAS  Google Scholar 

  • Byrne MJ, Davidson JA, Musk AW et al. (1999) Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study. J Clin Oncol 17:25–30

    PubMed  CAS  Google Scholar 

  • Carella R, Deleonardi G, D’Errico A et al. (2001) Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis. Am J Surg Pathol 25:43–50

    Article  PubMed  CAS  Google Scholar 

  • Churg A, Colby TV, Cagle P et al. (2000) The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 24:1183–1200

    Article  PubMed  CAS  Google Scholar 

  • Connelly RR, Spirtas R, Myers MH et al. (1987) Demographic patterns for mesothelioma in the United States. J Nat Cancer Inst 78:1053–1060

    PubMed  CAS  Google Scholar 

  • Craighead JE (1987) Current pathogenetic concepts of diffuse malignant mesothelioma. Hum Pathol 18:544–557

    PubMed  CAS  Google Scholar 

  • Crotty TB, Myers JL, Katzenstein AL, Tazelaar HD, Swensen SJ, Churg A (1994) Localized malignant mesothelioma. A clini-copathologic and flow cytometric study. Am J Surg Pathol 18:357–363

    Article  PubMed  CAS  Google Scholar 

  • Dazzi H, Thatcher N, Hasleton PS, Chatterjee AK, Lawson RA (1990) DNA analysis by flow cytometry in malignant pleural mesothelioma: relationship to histology and survival. J Pathol 162:51–55

    Article  PubMed  CAS  Google Scholar 

  • Dejmek A, Stromberg C, Wikstrom B, Hjerpe A (1992) Prognostic importance of the DNA ploidy pattern in malignant mesothelioma of the pleura. Anal Quant Cytol Histol 14:217–221

    PubMed  CAS  Google Scholar 

  • Dewar A, Valente M, Ring NP, Corrin B (1987) Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison. J Pathol 152:309–316

    Article  PubMed  CAS  Google Scholar 

  • El Naggar AK, Ordonez NG, Garnsey L, Batsakis JG (1991) Epithelioid pleural mesotheliomas and pulmonary adenocarcinomas: a comparative DNA flow cytometric study. Hum Pathol 22:972–978

    Article  PubMed  Google Scholar 

  • Garlepp MJ, Leong CC (1995) Biological and immunological aspects of malignant mesothelioma. Eur Respir J 8:643–650

    PubMed  CAS  Google Scholar 

  • Gazdar AF, Carbone M (2003) Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40. Clin Lung Cancer 5:177–181

    Article  PubMed  Google Scholar 

  • Goffrey MJ, Mills SE, Swanson PE, Zarbo RJ, Shah AR, Wick MR (1992) Immunoreactivity for BER-EP 4 in adenocarcinomas, adenomatoid tumors, and malignant mesotheliomas. Am Surg Pathol 16:593–599

    Article  Google Scholar 

  • Hammar SP (1993) Pleural diseases. In: Dail DH, Hammar SP (eds) Pulmonary pathology, 2nd edn. Springer, Berlin Heidelberg New York Tokyo, pp 1463–1579

    Google Scholar 

  • Heelan RT, Rusch VW, Begg CB et al. (1999) Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. Am J Roentgenol 172:1039–1047

    CAS  Google Scholar 

  • Hillerdal G (1994) Pleural plaques and risk for bronchial carcinoma and mesothelioma: a prospective study. Chest 105:144–150

    PubMed  CAS  Google Scholar 

  • Huncharek M (1994) Miliary mesothelioma. Chest 106:605

    PubMed  CAS  Google Scholar 

  • International Mesothelioma Interest Group (1995) A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 108:1122–1128

    Google Scholar 

  • Kawashima A, Lipshitz HI (1990) Malignant pleural mesothelioma: CT manifestations in 50 cases. Am J Roentgenol 155:965–969

    CAS  Google Scholar 

  • Kayser K et al. (2001) Glyco-and immunohistochemical refinement of the differential diagnosis between mesothelioma and metastatic carcinoma and survival analysis of patients. J Pathol 193:175–180

    Article  PubMed  CAS  Google Scholar 

  • Kayser K, Gabius HJ, Rahn W, Martin H, Hagemeyer O (1992) Variations of binding of labeled tumor necrosis factor alpha, epidermal growth factor, ganglioside GM-1 and N-acetylglucosamine, galactoside-specific mistletoe, lecithin and lecithin-specific antibodies in mesothelioma and metastatic adenocarcinoma of the pleura. Lung Cancer 8:185–192

    Article  Google Scholar 

  • Kindler HL, Meerbeck JP van (2002) The role of gemcitabine in the treatment of malignant mesothelioma. Semin Oncol 29:870–876

    Google Scholar 

  • Klemperer P, Rabin CB (1931) Primary neoplasms of the pleura. Arch Pathol 11:385–412

    Google Scholar 

  • Knuuttila A, Kivisaari A et al. (2001) Evaluation of pleural disease using MR and CT. With special reference to malignant pleural mesothelioma. Acta Radiol 42:502–507

    PubMed  CAS  Google Scholar 

  • Layer G, Schmitteckert H, Steudel A, Tuengerthal S, Schirren S, Kaick G van, Schild HH (1999) MRT, CT und Sonographie in der präoperativen Beurteilung der Primärtumorausdehnung beim malignen Pleuramesotheliom. Fortschr Röntgenstr 170:365–370

    CAS  Google Scholar 

  • Leung AN, Müller NL, Miller RR (1990) CT in differential diagnosis of diffuse pleural disease. Am J Roentgenol 154: 487–492

    CAS  Google Scholar 

  • Maasilta P, Vehmas T, Kivisaari L, Tammiletho L, Matson K (1991) Correlations between findings at computed tomography (CT) and at thoracoscopy/thoracotomy/autopsy in pleural mesothelioma. Eur Respir J 4:952–954

    PubMed  CAS  Google Scholar 

  • Mackay B, Lukeman JM, Ordonez NG (1991) Tumors of the pleura and chest wall. Tumors of the lung. Major Probl Pathol 323–364

    Google Scholar 

  • Mangano WE, Cagle PT, Churg A, Vollmer RT, Roggli VL (1998) The diagnosis of desmoplastic malignant mesothe-lioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining. Am J Clin Pathol 110:191–199

    PubMed  CAS  Google Scholar 

  • Marom EM, Erasmus JJ, Pass HI et al. (2002) The role of imaging in malignant pleural mesothelioma. Semin Oncol 29:26–35

    Article  PubMed  Google Scholar 

  • Mayo JR, MacKay AL, Whittal KP, Baile EM, Part PD (1995) Measurement of lung water content and pleural pressure gradient with magnetic resonance imaging. J Thorac Imaging 10:73–81

    Article  PubMed  CAS  Google Scholar 

  • McDonald AD, McDonald JC (1980) Malignant mesothelioma in North America. Cancer 46:1650–1656

    Article  PubMed  CAS  Google Scholar 

  • McLoud T, Flower C (1991) Imaging the pleura: sonography, CT, and MR Imaging. Am J Roentgenol 156:1145–1153

    CAS  Google Scholar 

  • Meerbeek JP van, Baas P, Debruyne C et al. (1999) A phase II study of gemcitabine in patients with malignant pleural mesothelioma. Cancer 85:2577–2582

    Article  Google Scholar 

  • Metintas M, Ucgun I, Elbek O et al. (2002) Computer tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol 41:1–9

    Article  PubMed  Google Scholar 

  • Mezger J (2000) Benigne und maligne Mesotheliome. In: Wilmanns W, Huhn D, Wilms K (eds) Internistische Onkologie, 2. Aufl. Thieme, Stuttgart, S 738–742

    Google Scholar 

  • Miller BH, Rosado-de-Christenson ML, Mason AC, Fleming MV, White CC, Krasna MJ (1996) Malignant pleural mesothelioma: radiologic-pathologic correlation. Radiographics 16:613–644

    PubMed  CAS  Google Scholar 

  • Moch H, Kiener S, Dalquen P, Gudat F (1993) Pseudomesothe-liomatous adenocarcinoma of the lung. Immunohistochemical study with special reference to detection of blood group isoantigens and Ber-EP4 antigen. Pathologe 14:11–15

    PubMed  CAS  Google Scholar 

  • Müller KM (1997) Mesothelioma. Pathology/pathogenesis/me-sothelioma register. Pneumologie 51:335–344

    PubMed  Google Scholar 

  • Neumann V, Gunthe S, Müller KM, Fischer M (2001) Malignant mesothelioma — German Mesothelioma Register 1987–1999. Int Arch Occup Environ Health 74:383–395

    Article  PubMed  CAS  Google Scholar 

  • Ong ST, Vogelzang NJ (1996) Chemotherapy in malignant pleural mesothelioma: a review. J Clin Oncol 14:1007–1017

    PubMed  CAS  Google Scholar 

  • Patz EF, Shaffer K, Piwnica-Worms DR, Jochelson M, Sarin M, Sugarbaker DJ, Pugatch RD (1992) Malignant pleural mesothelioma: value of CT and MR imaging in predicting re-sectability. Am J Roentgenol 159:961–966

    Google Scholar 

  • Patz EF Jr, McAdams HP, Erasmus JJ et al. (1998) Sclerotherapy for malignant pleural effusions: a prospective randomized trial of bleomycin vs. doxycycline with small-bore catheter drainage. Chest 113:1305–1311

    PubMed  CAS  Google Scholar 

  • Peterson JT, Greenberg SD, Buffier PA (1984) Non-asbestos-related malignant mesothelioma: a review. Cancer 54:951–960

    Article  PubMed  Google Scholar 

  • Peto J, Decarli A, La Vecchia C, Levi F, Negri E (1999) The European mesothelioma epidemic. Br J Cancer 79:666–672

    Article  PubMed  CAS  Google Scholar 

  • Pisani RJ, Colby TV, Williams DE (1988) Malignant mesothelioma of the pleura. Mayo Clin Proc 63:1234–1244

    PubMed  CAS  Google Scholar 

  • Roberts GH (1976) Distant visceral metastases in pleural mesothelioma. Br J Dis Chest 70:246–250

    Article  PubMed  CAS  Google Scholar 

  • Ruffle P, Feld R, Minkin S et al. (1989) Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 7:1157–1168

    Google Scholar 

  • Rusch VW (1996) A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. Lung Cancer 14:1–12

    Article  PubMed  CAS  Google Scholar 

  • Ryan CW, Herndon J, Vogelzang NJ (1998) A review of chemotherapy trials for malignant mesothelioma. Chest 113: 66S–73S

    PubMed  CAS  Google Scholar 

  • Schildge J, Kaiser D, Henss H et al. (1989) Prognostic factors in diffuse malignant mesothelioma of the pleura. Pneumologie 43:660–664

    PubMed  CAS  Google Scholar 

  • Selikoff U, Hammond EC, Seidman H (1980) Latency of asbestos disease among insulation workers in the United States and Canada. Cancer 46:2736–2740

    Article  PubMed  CAS  Google Scholar 

  • Steele JP, Shamash J, Evans MT et al. (2000) Phase II study of vinorelbine in patients with malignant pleural mesothelioma. J Clin Oncol 18:3912–3918

    PubMed  CAS  Google Scholar 

  • Sugarbaker DJ, Strauss GM, Lynch TJ et al. (1993) Node status has prognostic significance in the multimodality therapy of diffuse malignant mesothelioma. J Clin Oncol 11:1172–1178.

    PubMed  CAS  Google Scholar 

  • Sugarbaker DJ, Flores R, Jacklitsch M et al. (1999) Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 117:54–65

    Article  PubMed  CAS  Google Scholar 

  • Taguchi T, Jhanwar SC, Siegfried JM, Keller SM, Testa JR (1993) Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res 53:4349–4355

    PubMed  CAS  Google Scholar 

  • Vogelzang NJ (1992) Malignant mesothelioma: diagnostic and management strategies for 1992. Semin Oncol 19:64–71

    PubMed  CAS  Google Scholar 

  • Vogelzang NJ, Rusthoven J, Paoletti P et al. (2002) Phase III single-blinded study of pemetrexed + cisplatin vs. cisplatin alone in chemonaive patients with malignant pleural mesothelioma. Proc ASCO 21:2a

    Google Scholar 

  • Wagner JC, Sleggs CA, Marchand P (1960) Diffuse pleural mesothelioma and asbestos exposure in northwestern Cape Province. Br J Med 17:260–271

    CAS  Google Scholar 

  • Wechsler RJ, Rao VM, Steiner RM (1984) The radiology of thoracic malignant mesothelioma. Crit Rev Diagn Imaging 20:283–310

    PubMed  CAS  Google Scholar 

  • Wittekind C, Meyer HJ, Bootz F (Hrsg) (2002) UICC: TNM-Klassifikation maligner Tumoren, 6. Aufl. Springer, Berlin Heidelberg New York Tokio

    Google Scholar 

  • Wittekind C, Klimpfinger M, Sobin LH (Hrsg) (2005) TNM-At-las. Illustrierter Leitfaden zur TNM/pTNM-Klassifikation maligner Tumoren, 5. Aufl. Springer, Berlin Heidelberg New York Tokio

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Layer, G. (2006). Malignes Pleuramesotheliom. In: Layer, G., van Kaick, G., Delorme, S. (eds) Radiologische Diagnostik in der Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33565-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-33565-8_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-66991-3

  • Online ISBN: 978-3-540-33565-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics